The effect of Myo-inositol on improving sperm quality and IVF outcomes: A systematic review and meta-analysis
- PMID: 39619962
- PMCID: PMC11606893
- DOI: 10.1002/fsn3.4427
The effect of Myo-inositol on improving sperm quality and IVF outcomes: A systematic review and meta-analysis
Abstract
Myo-inositol may be efficient to improve sperm parameters to increase the chance of fertility. Although, the data are controversial. This study aimed to assess the impact of Myo-inositol supplements on semen quality and in vitro fertilization (IVF) outcomes. In this systematic review and meta-analysis, a comprehensive search was conducted in PubMed, Web of Science, and Embase. The objective was to identify relevant human studies that investigated the effects of Myo-inositol treatment on various sperm factors, such as sperm motility, sperm concentration, sperm morphology, viable spermatozoa, spermatozoa with DNA fragmentation, and pregnancy rate. Additionally, the testosterone levels of patients with Oligo-astheno-teratozoospermia (OAT) after Myo-inositol application were considered. The findings of 16 selected studies from 2240 citations indicated significant improvements in several parameters of sperm after Myo-inositol administration. Myo-inositol treatment was associated with a notable increase in total sperm motility (SMD 0.90; 95% CI: 0.34 to 1.46; I 2 = 0%, p = .001) and progressive sperm motility (SMD 1.48; 95% CI: 0.37 to 2.59; I 2 = 0%, p = .008). Additionally, there was a significant improvement in testosterone levels (SMD 0.54; 95% CI: 0.34 to 0.73; I 2 = 0%, p < .0001). Furthermore, Myo-inositol therapy demonstrated a significant decrease in spermatozoa with DNA fragmentation (SMD -1.37; 95% CI: -2.43 to -0.32; I 2 = 85%, p = .01). This study suggests that Myo-inositol therapy has a positive impact on specific sperm parameters, such as total and progressive sperm motility, along with testosterone levels. These findings provide support for the potential benefits of Myo-inositol in improving male fertility parameters related to sperm factors.
Keywords: Myo‐inositol; inositol; meta‐analysis; oligo‐astheno‐teratozoospermia; semen analysis; sperm parameters; systematic review.
© 2024 The Author(s). Food Science & Nutrition published by Wiley Periodicals LLC.
Conflict of interest statement
The authors have no conflict of interest to declare.
Figures




Similar articles
-
Myoinositol: does it improve sperm mitochondrial function and sperm motility?Urology. 2012 Jun;79(6):1290-5. doi: 10.1016/j.urology.2012.03.005. Urology. 2012. PMID: 22656408
-
In vitro effect of myo-inositol on sperm motility in normal and oligoasthenospermia patients undergoing in vitro fertilization.Gynecol Endocrinol. 2017 Feb;33(2):109-112. doi: 10.1080/09513590.2016.1254179. Epub 2016 Dec 2. Gynecol Endocrinol. 2017. PMID: 27908215
-
Combined treatment with myo-inositol, alpha-lipoic acid, folic acid and vitamins significantly improves sperm parameters of sub-fertile men: a multi-centric study.Eur Rev Med Pharmacol Sci. 2018 Oct;22(20):7078-7085. doi: 10.26355/eurrev_201810_16180. Eur Rev Med Pharmacol Sci. 2018. PMID: 30402876
-
Effects of Metabolic Syndrome on Semen Quality and Circulating Sex Hormones: A Systematic Review and Meta-Analysis.Front Endocrinol (Lausanne). 2020 Aug 11;11:428. doi: 10.3389/fendo.2020.00428. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32849258 Free PMC article.
-
Myo-inositol in health and disease: its impact on semen parameters and male fertility.Andrology. 2020 Mar;8(2):277-298. doi: 10.1111/andr.12718. Epub 2019 Nov 17. Andrology. 2020. PMID: 31637826 Review.
Cited by
-
A Narrative Review on the Sperm Selection Methods in Assisted Reproductive Technology: Out with the New, the Old Is Better?J Clin Med. 2025 Feb 7;14(4):1066. doi: 10.3390/jcm14041066. J Clin Med. 2025. PMID: 40004597 Free PMC article. Review.
References
-
- Abdolsamadi, M. , Mohammadi, F. , Nashtaei, M. S. , Teimouri, M. , Sardar, R. , Dayani, M. , Haghighi, M. , Ghasemi, S. , Vatannejad, A. , & Zandieh, Z. (2020). Does myoinositol supplement improve sperm parameters and DNA integrity in patients with oligoasthenoteratozoospermia after the freezing‐thawing process? Cell and Tissue Banking, 21(1), 99–106. 10.1007/s10561-019-09801-7 - DOI - PubMed
-
- Agarwal, A. , Majzoub, A. , Baskaran, S. , Panner Selvam, M. K. , Cho, C. L. , Henkel, R. , Finelli, R. , Leisegang, K. , Sengupta, P. , Barbarosie, C. , Parekh, N. , Alves, M. G. , Ko, E. , Arafa, M. , Tadros, N. , Ramasamy, R. , Kavoussi, P. , Ambar, R. , Kuchakulla, M. , … Shah, R. (2020). Sperm DNA fragmentation: A new guideline for clinicians. The World Journal Of Men's Health, 38(4), 412–471. 10.5534/wjmh.200128 - DOI - PMC - PubMed
-
- Artini, P. G. , Casarosa, E. , Carletti, E. , Monteleone, P. , Di Noia, A. , & Di Berardino, O. M. (2017). In vitro effect of myo‐inositol on sperm motility in normal and oligoasthenospermia patients undergoing in vitro fertilization. Gynecological Endocrinology, 33(2), 109–112. 10.1080/09513590.2016.1254179 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources